Trials / Completed
CompletedNCT01079663
The Efficacy and Safety of Chlorhexidine Gluconate Chip (Periochip®) in Therapy of Symptoms in Patients With Peri-implantitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Dexcel Pharma Technologies Ltd. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy and the safety of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis.
Detailed description
This is a Phase 2a study assessing the safety and efficacy of Chlorhexidine Gluconate chip (Periochip®) versus Placebo Chip in treatment of symptoms in patients with Peri-Implantitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Chlorhexidine 2.5 mg | |
| DRUG | Placebo chip |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2011-10-01
- Completion
- 2011-11-01
- First posted
- 2010-03-03
- Last updated
- 2021-06-15
- Results posted
- 2021-06-15
Locations
2 sites across 1 country: Israel
Source: ClinicalTrials.gov record NCT01079663. Inclusion in this directory is not an endorsement.